This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Biopharma Remove Healthcare Provider Remove Pharmaceutical manufacturing Related Topics
Pharmaceutical products Specialization Leads Healthcare Doctors Competition Safety Patients Pharma Food More Related Topics >
article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

Pharmaceutical 52
Pharmaceutical Manufacturing Food Healthcare Provider 52
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. Defossilization of pharmaceutical manufacturing. Biopharma successful in achieving climate-related goals, report finds … . 33, February 2022, 100586.

Manufacturing 77
Manufacturing Pharmaceutical Healthcare Healthcare 77
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024